Barriers to and facilitators of first-line treatment intensification (TI) in metastatic castration-sensitive prostate cancer (mCSPC) by practice setting and intensification frequency: A sub-analysis of IMPLEMENT.
| Publicado en: | Journal of Clinical Oncology Vol. 43; pp. 48 - 336 |
|---|---|
| Autores principales: | , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
American Society of Clinical Oncology
2/20/2025 Supplement 5
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| Descripción no disponible. |